Molecular Formula | C22H22N2O6 |
Molar Mass | 410.42 |
Density | 1.268±0.06 g/cm3(Predicted) |
Boling Point | 587.3±60.0 °C(Predicted) |
pKa | 1.82±0.10(Predicted) |
Storage Condition | 2-8°C |
In vitro study | Darusentan ((S)-Darusentan) competes for radiolabeled endothelin binding in rat aortic vascular smooth muscle cells (RAVSMs) membranes with single-site kinetics, exhibiting a K i =13 nM. In isolated endothelium-denuded rat aortic rings, Darusentan inhibits endothelin-induced vascular contractility with a pA 2 =8.1±0.14. Darusentan ( 0.001-1μM) inhibits ET-1-induced signaling in cultured RAVSMs. |
1mg | 5mg | 10mg | |
---|---|---|---|
1 mM | 2.437 ml | 12.183 ml | 24.365 ml |
5 mM | 0.487 ml | 2.437 ml | 4.873 ml |
10 mM | 0.244 ml | 1.218 ml | 2.437 ml |
5 mM | 0.049 ml | 0.244 ml | 0.487 ml |